Related Experiment Video

Updated: Aug 10, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Epidemiology of chronic hepatitis in Perth, Western Australia

R A Joske, W D Reed, W N Bartholomaeus

    Annals of the Academy of Medicine, Singapore
    |April 1, 1980
    PubMed

    Insights

    This study surveyed 50 patients with active chronic hepatitis (ACH), finding varied causes including metabolic disease, drugs/alcohol, and hepatitis B. Autoantibodies were common, and outcomes included improvement, death, or ongoing treatment.

    Area of Science:

    • Hepatology
    • Immunology

    Background:

    • Active chronic hepatitis (ACH) presents diverse etiologies and clinical courses.
    • Understanding the demographic and etiological factors in ACH is crucial for patient management.

    Purpose of the Study:

    • To investigate the etiological spectrum and clinical characteristics of active chronic hepatitis in Perth, Western Australia.
    • To analyze the prevalence of autoantibodies and patient outcomes in this cohort.

    Main Methods:

    • A survey of 50 patients diagnosed with active chronic hepatitis.
    • Etiological classification based on metabolic disease, drug/alcohol use, hepatitis B, or idiopathic causes.
    • Assessment of autoantibody presence, demographic data, and treatment outcomes.

    Main Results:

    • The etiology of ACH varied, with 27 cases being idiopathic, 12 due to hepatitis B, and others linked to metabolic disease, drugs, or alcohol.
    • A male predominance was observed in non-idiopathic groups, while the idiopathic group showed a female predominance.
    • Autoantibodies were detected in 40 patients, most frequently antismooth muscle antibody (24 cases) and antinuclear factor (13 cases).
    • Patient outcomes included 12% improvement, 14% mortality, and 74% remaining on treatment.

    Conclusions:

    • Active chronic hepatitis in Perth exhibits a broad range of causes and demographic distributions.
    • Autoantibody positivity is common in ACH patients, suggesting an autoimmune component in some cases.
    • Outcomes for ACH patients are variable, with a significant proportion requiring long-term management.

    More Related Videos

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
    Chronic Pancreatitis I: Introduction01:25

    Chronic Pancreatitis I: Introduction

    Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
    Chronic Pancreatitis II: Pathophysiology01:21

    Chronic Pancreatitis II: Pathophysiology

    Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...